Weyergans High Care AG is a medium-sized small company from the west Rhineland-Palatinate. The core competence of the company lies in the area of research, development and production of innovative medical applications. Renowned research partners such as the Institute for Aerospace Medicine at the German Aerospace Association, the Institute for Biomedical Technology of the University Aachen, Germany, or the Max - Planck Institute for experimental medicine in Goettingen, Germany, as well as a large international network support the company in its mission.
The main claim lies on technical and ergonomic quality, evidence and sustainability.
The Weyergans High Care AG has numerous patents available and is internationally represented in approximately 40 countries.